Keith Meister, Eli Casdin's third SPAC to merge with biotech EQRx
06/08/2021 12:03
Aug 6 (Reuters) - CM Life Sciences III CMLT.O , the third blank-check backed by activist investor Keith Meister and life sciences investor Eli Casdin, will take EQRx Inc public in a deal that would give the biotech firm $1.8 billion in cash, the companies said on Friday. (Reporting by Niket Nishant in Bengaluru; editing by Vinay Dwivedi) ((Niket.Nishant@thomsonreuters.com;))
Recent news on EQRx
See all newsBrief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc
Brief: Revolution Medicines Inc Says Will Acquire EQRx In An All-Stock Transaction
U.S. RESEARCH ROUNDUP- Cigna Group, McKesson, Zscaler
Brief: EQRx posts Q1 EPS USD -0.17
Brief: EQRx Says Jami Rubin Will Step Down As Chief Financial Officer